Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05354115 · ClinicalTrials.gov registry record · NA
Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.
A NA study, sponsored by Abbott Rapid Dx.
- Completed
- Registry status
- NA
- Development phase
- 676
- Enrollment target
NCT05354115: Completed NA study, sponsored by Abbott Rapid Dx.
NCT05354115 is a NA study that has completed, run by Abbott Rapid Dx. The registered enrollment target is 676 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05354115, a NA study, has completed, sponsored by Abbott Rapid Dx.
- COMPLETED
- Registry status
- NA
- Development phase
- 676 participants
- Enrollment target
Study Summary
This study is designed as a prospective, multicentric, sample collection study. The collected samples will be used for diagnostic research, product development and validation of the Panbio™ COVID-19/ Flu A\&B Rapid Panel for the qualitative detection of COVID-19 antigen, Influenza A antigen (H1N1 and H3N2), and Influenza B antigen in human nasal and nasopharyngeal swabs by the study sponsor, Abbott.
Primary Outcome
The objective of this study is to collect nasal and nasopharyngeal swab specimens from individuals suspected of respiratory viral infection consistent with COVID-19 and/or Flu by their healthcare provider within the first five days of the onset of symptoms. The collected samples will be sent to the sponsor (Abbott) or central laboratory for reference testing, diagnostic research, product development and validation of the Panbio™ COVID-19/ Flu A\&B Rapid Panel some of which will be used to suppor
Interventions
- DIAGNOSTIC_TEST Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 676 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-08-22 |
| Phase | NA |
What the finished NCT05354115 record still lists
NCT05354115 is an interventional study that assigns participants to a tested intervention. The registered 676 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 1 intervention - of which Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel is the first listed.
NCT05354115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05354115 about?
NCT05354115 is a clinical study titled "Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.". This study is designed as a prospective, multicentric, sample collection study. The collected samples will be used for diagnostic research, product development and validation of the Panbio™ COVID-19/ Flu A\&B Rapid Panel for the qualitative detection of COVID-19 antigen, Influenza A antigen (H1N1 an...
What is the current status of trial NCT05354115?
This trial is currently completed. It is a NA study. The enrollment target is 676 participants. The study started on 2022-03-14. Estimated completion is 2022-08-22.
What interventions are being tested in trial NCT05354115?
The interventions under investigation include: Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05354115?
This trial is sponsored by Abbott Rapid Dx, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05354115's enrollment target sits among peer trials
676 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07227337 · 676 participants · NA
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
- NCT06070870 · 675 participants · NA
Health Education Approach to Lung Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI